Product Information
TRIAMCINOLONE 55 MCG NASAL SPR is a generic product labeled by Apotex Corp., priced at $0.7388 per ML under NDC 60505627507. Its NADAC has been published 127 times since May 1, 2024.
FDA first approved this application on Jan 19, 2023.
Strength
55 ug/1
Manufacturer
Apotex Corp.NDC
60505627507
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214615FDA Approved
1/19/2023
On Market Since
1/26/2024
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has been published 127 times since May 1, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7388 per ML |
|---|---|
| All-time high | $0.7861 (Sep 11, 2024) |
| All-time low | $0.6910 (May 22, 2024) |
| 52-week high | $0.7720 |
| 52-week low | $0.7136 |
| Median price | $0.7360 |
| Average price | $0.7374 |
| Largest weekly change | -9.1% (Nov 20, 2024) |
| Weeks tracked | 127 |
| Tracking since | May 1, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 55 MCG NASAL SPR?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 55 MCG NASAL SPR, manufactured by Apotex Corp., is $0.7388 per ML (NDC 60505627507), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 55 MCG NASAL SPR changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has held within roughly two percent of its current level. It has been tracked across 127 weekly CMS publications since May 1, 2024.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 55 MCG NASAL SPR?
Since May 1, 2024, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has ranged from a low of $0.6910 (May 22, 2024) to a high of $0.7861 (Sep 11, 2024), with a median of $0.7360 per ML.
Are there cheaper alternatives to TRIAMCINOLONE 55 MCG NASAL SPR?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL ALLERGY 24HR SPRAY, is $0.7229 per ML — about 2% below TRIAMCINOLONE 55 MCG NASAL SPR.
Who manufactures TRIAMCINOLONE 55 MCG NASAL SPR?
TRIAMCINOLONE 55 MCG NASAL SPR (NDC 60505627507) is labeled by Apotex Corp., and CMS classifies it as a generic product.